Quantcast

Latest Biogen Idec Stories

2014-07-26 23:01:46

MarketOptimizer.org adds “Multiple Sclerosis Global Clinical Trials Review, H2, 2014” to its store.

2014-07-23 16:27:46

RICHMOND, Calif., July 23, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.

2014-07-22 12:27:43

Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-07-16 16:23:59

RICHMOND, Calif., July 16, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.

2014-07-07 08:27:16

Editor Note: For more information about this release, please scroll to bottom. LONDON, July 7, 2014 /PRNewswire/ -- On Thursday, July 03, 2014, the NASDAQ Composite

2014-06-26 12:29:42

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-06-25 12:30:05

MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C.

2014-06-18 08:29:50

AMSTERDAM and PETACH TIKVA, Israel, June 18, 2014 /PRNewswire/ -- uniQure N.V.

2014-06-17 08:28:25

CARLSBAD, Calif., June 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.

2014-06-12 12:30:07

Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,


Word of the Day
shotta
  • An armed gangster.
The word 'shotta' is an alteration of 'shooter'.